Anti-MUC1 Monoclonal Antibody (C595) and Docetaxel Markedly Reduce Tumor Burden and Ascites, and Prolong Survival in an in vivo Ovarian Cancer Model
- Resource Type
- Journal
- Source
PLOS ONE ; SEP 9 2011, 6 9, pe24405 13p.- Subject
- Language
- English
- ISSN
- 19326203